CLDX icon

Celldex Therapeutics

130 hedge funds and large institutions have $183M invested in Celldex Therapeutics in 2017 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 42 increasing their positions, 41 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

18% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 17

28% less call options, than puts

Call options by funds: $577K | Put options by funds: $798K

38% less capital invested

Capital invested by funds: $295M → $183M (-$113M)

Holders
130
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$577K
Puts
$798K
Net Calls
Net Calls Change

Top Buyers

1 +$6.19M
2 +$4.09M
3 +$3.06M
4
Citadel Advisors
Citadel Advisors
Florida
+$2.02M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.75M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$1K
127
$1K
128
$267
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145